Saranya Chumsri, MD, and Adam M. Brufsky, MD, PhD, discuss the evaluation of Bria-IMT plus a checkpoint inhibitor in metastatic breast cancer
Examining the Novelty of Vaccine-Based Therapy in Metastatic Breast Cancer
Adam M. Brufsky, MD, PhD, FACP, discusses the unique design of the allogeneic GM-CSF–secreting breast cancer vaccine SV-BR-1-GM.
Advertisement
Advertisement
Trending on OncLive
1
FDA Flashback: GI Cancer Decisions and News From July 2026
2
TNFR2 Advances as a Novel Target for Restoring Antitumor Immunity Across Lymphoma and Solid Tumors
3
Phase 3 VERSATILE-003 Trial of PDS0101 in HNSCC Is Discontinued
4
CD24 Expression Confers Resistance to Anti–PD-1 Therapy in NSCLC, RET-TKI Dose Reductions Do Not Compromise Outcomes in RET+ Disease
5